immunology

Bristol Myers Squibb
May 12, 2026

Bristol Myers Squibb inks $15.2B drug deal with Hengrui

The partnership with Hengrui Pharma will develop 13 oncology, hematology and immunology drug programs worldwide.

Merck's headquarters in Rahway.
Jan 8, 2024

Merck’s $680M Harpoon acquisition to diversify oncology pipeline

According to Dr. Dean Li, president, Merck Research Laboratories, “This agreement reflects the creativity and commitment of scientists and clinical development teams at Harpoon," a South San Francisco-based clinical-stage immunotherapy company.